Therefore, it is worthy determining whether USP24 inhibitors can be a potential treatment for liver fibrosis as well as drug‐resistant cancers and we will persist in optimizing USP24 inhibitors in the future. This evidence concerns the gene USP24 and Hepatic fibrosis.